A method for preparing bovine pituitary extract and its application

By combining supercritical CO2 defatting and PEG-ammonium sulfate aqueous two-phase extraction, the problem of low purity and low retention rate of active substances in bovine pituitary extract was solved, enabling the preparation of high-purity, high-activity peptides, which are suitable as a culture medium additive for mesenchymal stem cells.

CN123063343APending Publication Date: 2026-11-10INNER MONGOLIA JINPUSAI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611545360.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-08
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies for preparing bovine pituitary extracts suffer from problems such as insufficient mechanical homogenization and disruption, low yield of active peptides, easy degradation of proteins and peptides due to acid and alkali extraction, poor selectivity of ethanol precipitation, and incomplete removal of impurities such as extraneous proteins and lipids, resulting in low purity of the extract.

Method used

A method combining supercritical CO2 degreasing followed by leaching and PEG-ammonium sulfate aqueous two-phase extraction purification was adopted. This method includes low-temperature thawing, ultra-low temperature freeze drying, supercritical CO2 fluid degreasing, PEG-ammonium sulfate aqueous two-phase extraction and ultrafiltration concentration, to construct a stepwise removal system based on impurity polarity from weak to strong and molecular weight from large to small.

Benefits of technology

It has achieved the preparation of highly active and high-purity bovine pituitary extract, with purity increased to 66.9%-68.3% and GH retention rate as high as 91.3%-95.6%, which is significantly better than traditional processes. Moreover, the ultrafiltration membrane has a low flux decay rate, supports long-term large-scale operation, and is green and environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063343A_ABST
    Figure CN123063343A_ABST
Patent Text Reader

Abstract

This invention discloses a method for preparing bovine pituitary extract and its application, belonging to the field of biomaterials and cell culture technology. The preparation method includes: (1) low-temperature freeze-drying and pulverizing bovine pituitary to obtain dry powder; (2) supercritical CO2 defatting treatment; (3) buffer extraction, centrifugation to obtain crude extract; (4) PEG-ammonium sulfate aqueous two-phase extraction, collecting the PEG phase; (5) ultrafiltration concentration, washing, filtration and sterilization to obtain the finished product. This invention uses supercritical defatting, aqueous two-phase extraction and ultrafiltration to form a synergistic purification system, removing lipids, nucleic acids and impurities stepwise according to the polarity of impurities from weak to strong and the molecular weight from large to small, reducing ultrafiltration membrane pollution and protecting membrane flux. The extract can significantly promote the proliferation of mesenchymal stem cells, shorten the culture cycle, and upregulate the gene expression levels of stem cell stemness-related transcription factors SOX2 and NANOG, maintaining stem cell stemness.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomaterials and cell culture technology, specifically a method for preparing and applying bovine pituitary extract. Background Technology

[0002] The pituitary gland, an important component of the central nervous system, is commonly referred to as the "hypophysis." It consists of two parts: the anterior pituitary and the neurohypophysis. The anterior pituitary contains six different clusters of endocrine cells that work together to synthesize and secrete many important bioactive peptides, including growth hormone (GH), prolactin (PRL), thyroid-stimulating hormone (TSH), and adrenocorticotropic hormone (ACTH). The neurohypophysis primarily functions as a storage and regulatory organ, responsible for storing and releasing two peptide hormones produced by the hypothalamus: antidiuretic hormone and oxytocin.

[0003] The exact chemical composition of bovine pituitary extract is currently unclear, but it is known to contain many active substances that play important roles, such as growth hormone, basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) and its derivatives, and platelet-derived growth factor. Some studies have shown that bovine pituitary extract can provide good support for keratinocytes cultured under serum-free conditions, especially for some difficult-to-culture epithelial cell lines, and can improve cell proliferation and differentiation potential.

[0004] Current research on pituitary extracts, both domestically and internationally, mainly focuses on the isolation and purification of one or more hormones.

[0005] Since the first extraction of growth hormone from bovine pituitary gland in the mid-20th century, related research has become increasingly rich and sophisticated, aiming to improve product quality and expand production scale. Traditional pituitary extract production processes typically involve homogenization, acid-base extraction, salting out, ethanol precipitation, and dialysis concentration. This process suffers from several drawbacks: insufficient mechanical homogenization results in low yields of active peptides and growth hormone; prolonged acid-base extraction easily leads to protein and peptide degradation; and ethanol precipitation exhibits poor selectivity, resulting in incomplete removal of impurities such as proteins and lipids, leading to low purity. Therefore, obtaining highly active and pure bovine pituitary extract has become a pressing issue that needs to be addressed. Summary of the Invention

[0006] To address the above problems, this invention provides a novel preparation method using supercritical CO2 defatting followed by extraction, coupled with PEG-ammonium sulfate aqueous two-phase extraction purification, specifically including the following steps: I. Preparation of Bovine Pituitary Gland Powder (1) Thaw the bovine pituitary gland at low temperature to ensure a gentle process; (2) Quickly remove the capsule and connective tissue, rinse thoroughly with pre-cooled PBS 3-5 times to remove surface blood, and place on sterile filter paper to absorb surface free moisture after rinsing. (3) Cut the washed and dried bovine pituitary gland into uniform thin slices with a thickness of 2-3 mm, and lay them in a single layer on a sterile freeze-drying tray. (4) Place the prepared tray in an ultra-low temperature freezer at -80℃ for 6 hours, then quickly transfer it to a vacuum freeze dryer. Turn on the vacuum system, set the vacuum degree to ≤10Pa, the shelf temperature to -20 to 20℃, and freeze dry for 30-42 hours. (5) After observing that the sample volume has shrunk significantly and hardened, slowly raise the temperature of the partition to 10-20℃, keep the vacuum level constant, and continue to desorb and dry for 6-12 hours. Weigh the sample twice at 2-hour intervals. If the mass difference is less than 0.5%, the drying is complete. (6) After drying, divide the pituitary sample into 10g portions, put them into sealed bags, and immerse them in a liquid nitrogen insulated container to freeze for 20 minutes to make the sample completely frozen and brittle. (7) Quickly transfer the freeze-dried sample into a sterile high-speed grinder and use an intermittent low-temperature grinding mode: grind for 3-5 seconds each time, let it stand and cool for 10 seconds, repeat 6-8 times, and keep the chamber temperature below 30℃ throughout the process. (8) After pulverization, immediately pass the powder through an 80-mesh sterile standard sieve in a clean bench. Coarse particles on the sieve will be frozen and pulverized again with liquid nitrogen until all the powder passes through the sieve. Then, pack the powder into a self-sealing bag, seal it, and dry it for later use.

[0007] II. Supercritical CO2 fluid degreasing and refining (1) Under aseptic conditions, accurately weigh bovine pituitary powder, spread it evenly on the sieve plate of the supercritical reactor, and seal and lock all interfaces of the reactor after filling. (2) Turn on the equipment temperature control system and raise the temperature of the reactor to 40°C at a uniform rate. Turn on the CO2 high-pressure delivery pump and slowly introduce liquid CO2, raising the pressure to 35MPa at a uniform rate to avoid sudden pressure changes that could damage the active structure of the sample.

[0008] (3) Static soaking for 30 minutes under constant temperature of 40℃ and pressure of 35MPa allows the supercritical CO2 fluid to fully penetrate and combine with fat-soluble impurities, oils, and pigments to form a uniform extraction phase system. (4) Turn on the fluid circulation system, set the CO2 fluid flow rate to 20L / h, and perform dynamic circulation degreasing for 1.5h under constant temperature and pressure conditions; (5) The degreased CO2 fluid containing impurities enters the separation vessel. The pressure of the separation vessel is adjusted to 8 MPa and the temperature to 35°C. Supercritical CO2 phase change desorption occurs, and fat-soluble oils, pigments, and impurities settle to the bottom of the separation vessel. The pure CO2 fluid is circulated back to the main reaction vessel to achieve continuous degreasing and media recycling. (6) After degreasing, turn off the CO2 delivery pump and heating system, and slowly depressurize to atmospheric pressure at a rate of 0.3 MPa / min to avoid sample splashing and damage to the active structure caused by rapid depressurization; (7) After the pressure is released, open the reactor and collect the defatted solid sample, which is the defatted and purified intermediate. Quickly cool it to 4°C and seal it for later use.

[0009] III. Aqueous-phase extraction of bovine pituitary extract (1) Take defatted solids and add PBS buffer (pH 7.0) at a ratio of 1:10 to the solids. Stir at low speed at 4°C for 3 hours to extract. (2) Centrifuge at 10000r / min for 10min at 4℃, and take the supernatant to obtain the crude pituitary extract; (3) The crude extract was filtered through a 0.45 μm filter membrane to remove tiny insoluble particles; (4) Preparation of a two-phase aqueous system (total mass 100g): Add 13g PEG4000, 16g anhydrous ammonium sulfate, and 51g ultrapure water in sequence, and stir at room temperature until completely dissolved; (5) Take 20g of the crude pituitary extract and add it to the prepared aqueous two-phase system. Vortex and mix thoroughly. Let it stand in a water bath at 25°C for 20 minutes. (6) Centrifuge at 5000 r / min for 10 min at room temperature. The system forms two clear layers. The upper layer (PEG phase) is the target phase, which is enriched with active peptides and small molecule proteins. The lower layer (salt phase) is rich in polysaccharides, nucleic acids, denatured proteins, etc. Slowly aspirate the upper PEG phase to avoid aspirating impurities. (7) Transfer the aspirated PEG phase into a 10 kDa ultrafiltration centrifuge tube, ultrafilter at 4℃ and 8000 r / min, concentrate to 1 / 3 of the original volume, add an equal volume of ultrapure water and wash repeatedly 3 times to remove ammonium sulfate and PEG, and collect the retentate. (8) Centrifuge the retentate at 4℃ and 10000r / min for 10min, collect the supernatant, and discard the trace amounts of precipitated insoluble impurities; (9) The supernatant was filtered through a 0.22μm PVDF membrane, dispensed, and stored frozen at -20℃.

[0010] Compared with the prior art, the present invention has the following beneficial effects: 1. This invention is the first to combine supercritical CO2 defatting, PEG-ammonium sulfate aqueous two-phase extraction, and ultrafiltration concentration to construct a stepwise removal system based on impurity polarity from weak to strong and molecular weight from large to small. Supercritical defatting first removes lipid-soluble impurities, eliminating their interference with the stability of the phase interface of the aqueous two-phase system and ensuring clear phase separation. PEG-ammonium sulfate aqueous two-phase extraction further removes high molecular weight impurities such as proteins, polysaccharides, and nucleic acids, reducing the fouling load on the ultrafiltration membrane. Ultrafiltration finally retains the target peptides and removes residual small molecule salts and PEG. The three steps work synergistically and complementarily to achieve precise and efficient removal of various impurities.

[0011] 2. The bovine pituitary extract prepared by this invention has a purity of 66.9%-68.3%, which is about 2.4 times that of traditional processes; the GH retention rate is as high as 91.3%-95.6%, and ELISA detection confirms that various endogenous active substances such as GH, TGF-β1, IGF-1, and TSH are effectively retained. In contrast, the GH retention rate of the traditional acid extraction-alcohol precipitation process is less than 50%, and high-temperature defatting (60°C) also causes the GH retention rate to drop sharply to 62.6%, which fully demonstrates that the mild preparation conditions of this invention have an excellent protective effect on heat-sensitive active peptides.

[0012] 3. In this invention, supercritical CO2 defatting can reduce lipid residue by more than 95%; the PEG-ammonium sulfate aqueous two-phase system can efficiently distribute nucleic acids to the salt phase, with nucleic acid residue as low as 4.2-4.5 μg / mg protein, which is significantly better than the potassium phosphate aqueous two-phase system, demonstrating the specific advantages of the preferred system of this invention.

[0013] 4. The synergistic purification system of this invention effectively protects the ultrafiltration membrane flux, with a flux decay rate of only 8.2%-9.3%, supporting long-term, large-scale continuous concentration operations. In contrast, Comparative Example 1, without any pretreatment, directly ultrafiltered, resulting in a membrane flux decay rate as high as 73.5%, making the process unsustainable. Furthermore, the supercritical CO2 fluid can be recycled, making the process green and environmentally friendly, meeting the clean production requirements of modern biopharmaceuticals.

[0014] 5. Cell experiments showed that the bovine pituitary extract prepared in this invention, when added to the culture medium, resulted in no significant difference in the survival rate of BMSCs (97.61%) compared to the control group (97.30%), demonstrating its good biocompatibility; CCK-8 proliferation assays showed that the OD values ​​of the 3% BPE experimental group at various time points were... 450 The values ​​were all higher than those of the 10% FBS control group, and the cell growth curve showed a typical S-shape, indicating that the extract can effectively promote the proliferation of mesenchymal stem cells and shorten the culture period. RT-qPCR results showed that the expression levels of SOX2 and NANOG genes in the experimental group were significantly upregulated, while the expression of OCT4 did not change significantly, proving that the extract can maintain stem cell stemness, inhibit premature differentiation, and delay aging while promoting proliferation. Therefore, the extract of this invention can be used as a cell culture medium additive and has important application value in the large-scale in vitro expansion culture of mesenchymal stem cells. Attached Figure Description

[0015] Figure 1 This is the standard curve for BSA protein. Figure 2 The proliferation curves of rat BMSCs cells in the control and experimental groups using CCK-8 inhibitors are shown. Figure 3 This is a graph showing the expression analysis of the OCT4, SOX2, and NANOG genes. Detailed Implementation

[0016] Example 1 This embodiment provides a method for preparing bovine pituitary extract, including the following steps: (1) Preparation of bovine pituitary gland powder Take fresh bovine pituitary glands and thaw them slowly at 2-8℃ for 12 hours. After complete thawing, quickly remove the capsule and connective tissue using sterile forceps and surgical scissors. Rinse five times with pre-cooled PBS buffer (pH 7.0, 4℃), replacing the PBS each time, until the rinse solution is clear and free of blood. Place the washed pituitary glands on sterile filter paper, blot off any surface moisture, and then slice them into uniform thin slices 2-3 mm thick using a sterile blade. Lay them in a single layer on a sterile freeze-drying tray.

[0017] Pre-freeze the tray in an ultra-low temperature freezer at -80℃ for 6 hours, then quickly transfer it to a vacuum freeze dryer. Turn on the vacuum system, set the vacuum level to ≤10Pa, the partition temperature to -20℃, and freeze-dry for 30 hours. After observing significant shrinkage and hardening of the sample volume, slowly raise the partition temperature to 10℃, maintain the vacuum level, and continue desorption drying for 12 hours. Weigh twice at 2-hour intervals; a mass difference of 0.3% (<0.5%) indicates that drying is complete.

[0018] The dried pituitary sample was divided into 10g portions, placed in sealed bags, and immersed in a liquid nitrogen insulated container for 20 minutes to freeze until the sample was completely brittle. After removal, it was quickly transferred to a sterile high-speed grinder and subjected to intermittent low-temperature grinding: 5 seconds of grinding followed by 10 seconds of cooling, repeated 8 times, with the chamber temperature maintained below 30°C throughout. Immediately after grinding, the sample was passed through an 80-mesh sterile standard sieve in a laminar flow hood. Coarse particles remaining on the sieve were re-crystallized in liquid nitrogen until all powder passed through the sieve. The powder was then placed in a self-sealing bag, sealed, and dried for later use.

[0019] (2) Supercritical CO2 fluid degreasing and refining Under aseptic conditions, accurately weigh 200g of bovine pituitary powder obtained in step (1), spread it evenly on the sieve plate of the supercritical reactor, and seal and lock all interfaces of the reactor after filling.

[0020] Turn on the equipment temperature control system and raise the temperature of the reactor to 40°C at a uniform rate. Turn on the CO2 high-pressure delivery pump and slowly introduce liquid CO2, raising the pressure to 35 MPa at a uniform rate. Maintain a constant temperature of 40°C and a pressure of 35 MPa for static soaking for 30 minutes to allow the supercritical CO2 fluid to fully penetrate and combine with the fat-soluble impurities.

[0021] The fluid circulation system was started, and the CO2 fluid flow rate was set to 20 L / h. Dynamic degreasing was carried out for 1.5 h under constant temperature and pressure. The degreased CO2 fluid containing impurities entered the separation vessel. The pressure of the separation vessel was adjusted to 8 MPa and the temperature to 35 °C to allow supercritical CO2 phase change desorption. Fat-soluble oils, pigments, and impurities settled at the bottom of the separation vessel, and the pure CO2 fluid was circulated back to the main reactor.

[0022] After defatting, turn off the CO2 delivery pump and heating system, and slowly depressurize to atmospheric pressure at a rate of 0.3 MPa / min. After depressurization, open the reactor, collect the defatted solid sample, weigh 182 g, which is the defatting and purification intermediate. Quickly transfer the obtained intermediate to a low-temperature environment to cool to 4°C, seal and store for later use.

[0023] (3) Aqueous two-phase extraction of bovine pituitary extract Take 50g of the defatted solid obtained in step (2), add 500mL of pH 7.0 PBS buffer (pre-cooled at 4℃) at a material-to-liquid ratio of 1:10, and extract at low speed with magnetic stirring at 4℃ for 3h. After extraction, centrifuge at 10000r / min for 10min at 4℃, take the supernatant to obtain the pituitary crude extract, filter the crude extract through a 0.45μm filter membrane to remove small insoluble particles, the volume is about 420mL.

[0024] Prepare an aqueous two-phase system (total mass 100g): Add 13g PEG4000, 16g anhydrous ammonium sulfate, and 51g ultrapure water sequentially, and stir at room temperature until completely dissolved. Add 20g of pituitary extract to the prepared aqueous two-phase system (i.e., scale up to a total volume of approximately 500mL), vortex to mix thoroughly, and incubate at 25°C for 30min. Then centrifuge at 5000r / min for 10min at room temperature. The system forms two clear layers: the upper layer is the PEG phase (target phase, enriched with active peptides and small proteins), and the lower layer is the salt phase (rich in polysaccharides, nucleic acids, denatured proteins, etc.). Slowly aspirate the upper PEG phase, avoiding aspiration of the lower layer impurities, and collect approximately 260mL of the PEG phase.

[0025] (4) Ultrafiltration concentration and purification The PEG phase collected in step (3) was aliquoted into 10 kDa ultrafiltration centrifuge tubes (15 mL per tube) and ultrafiltered at 4 °C and 8000 r / min to concentrate to 1 / 3 of the original volume. An equal volume of ultrapure water was added and the tubes were washed three times to remove residual ammonium sulfate and PEG. The retentate was collected and combined to a volume of approximately 75 mL.

[0026] The retentate was centrifuged at 10,000 r / min for 10 min at 4℃, and the supernatant was collected. Trace amounts of precipitated insoluble impurities were discarded. The supernatant was filtered through a 0.22 μm PVDF membrane, dispensed, and stored frozen at -20℃ to obtain the bovine pituitary extract.

[0027] Example 2 The difference between this embodiment and embodiment 1 is that the process parameters for supercritical CO2 degreasing in step (2) are different.

[0028] Specifically, in step (2): the equipment temperature control system is turned on, and the temperature of the reactor is raised to 45°C at a constant rate. The CO2 high-pressure delivery pump is turned on, and liquid CO2 is slowly introduced, with the pressure raised to 30MPa at a constant rate. The reactor is statically soaked for 40 minutes under constant temperature of 45°C and pressure of 30MPa. The fluid circulation system is turned on, and the CO2 fluid flow rate is set to 25L / h for dynamic circulation degreasing for 2 hours. The conditions of the separation vessel are adjusted to pressure of 10MPa and temperature of 40°C. The remaining steps and parameters are exactly the same as in Example 1.

[0029] Example 3 The difference between this embodiment and embodiment 1 is that the composition ratio of the two-phase aqueous system in step (3) is different, and the ultrafiltration parameters in step (4) are adjusted accordingly.

[0030] Specifically, the aqueous two-phase system in step (3) consists of: 16g of PEG4000, 18g of anhydrous ammonium sulfate, and 46g of ultrapure water (total mass 100g). 20g of the crude pituitary extract is added to the system, and the remaining operations are the same as in Example 1.

[0031] In step (4): the volume is concentrated to 1 / 2 of the original volume, washed 4 times by displacement, and the ultrafiltration speed is 6000 r / min. The remaining steps are exactly the same as in Example 1.

[0032] Example 4 This embodiment provides a specific application of culturing rat BMSCs cells using the bovine pituitary extract prepared in Example 1.

[0033] Take well-grown P3 generation rat BMSCs, discard the culture medium, wash twice with PBS, add 1 mL of 0.25% trypsin-EDTA digestion solution, digest at 37℃ for 2 min, add DMEM / F12 medium containing 10% FBS to terminate digestion, gently pipette to prepare a single-cell suspension, count and adjust the cell concentration to 1×10⁶. 4 per mL.

[0034] The experimental group's complete culture medium contained 6% FBS, 3% bovine pituitary extract (prepared in Example 1), 90% DMEM / F12 basal medium, and 1% penicillin-streptomycin antibiotics. The control group's complete culture medium contained 10% FBS, 89% DMEM / F12 basal medium, and 1% penicillin-streptomycin antibiotics.

[0035] Cells were seeded into 6-well plates, with 2 mL of cell suspension in each well. The experimental and control culture media were added separately, and the plates were incubated at 37°C in a 5% CO2 saturated humidity incubator. The medium was changed every 2 days, and cell morphology and growth were observed daily under an inverted microscope.

[0036] After 7 days of culture, the results showed that the cell density in the experimental group was significantly higher than that in the control group. The cells exhibited a typical spindle shape, arranged in a spiral pattern, and showed no signs of abnormal apoptosis or aging. This indicates that the bovine pituitary extract prepared in this invention can effectively support the in vitro expansion of BMSCs.

[0037] Example 5 This embodiment provides a method for preparing lyophilized powder of bovine pituitary extract, which is beneficial for long-term preservation and transportation.

[0038] The ultrafiltration retentate (pH 7.0) obtained in Example 1 was dispensed into sterile lyophilized vials, 5 mL per vial, using a clean bench. The vials were partially stoppered and transferred to a vacuum freeze dryer. The refrigeration system was turned on, and the sample temperature was lowered to -40°C for pre-freezing for 4 hours. After pre-freezing, the vacuum system was turned on, setting the vacuum level to ≤5 Pa and the separator temperature to -10°C for sublimation drying, which was maintained for 24 hours. Subsequently, the separator temperature was slowly raised to 20°C, and desorption drying continued for 8 hours. After drying, sterile nitrogen gas was introduced to atmospheric pressure, and the vials were quickly stoppered and capped to obtain the lyophilized bovine pituitary extract powder.

[0039] This lyophilized powder can be stably stored at -20℃ for more than 12 months. Before use, it can be reconstituted with sterile water for injection to the original volume.

[0040] Comparative Example 1 This comparative example uses the same raw materials and operating steps as the example, but omits step (2) supercritical CO2 defatting and step (4) PEG-ammonium sulfate aqueous two-phase extraction. The bovine pituitary dry powder is directly extracted with PBS buffer and then ultrafiltered. The remaining steps are consistent with the example.

[0041] The specific operation is as follows: Take 50g of bovine pituitary powder prepared according to step (1) of Example 1, add 500mL of pH 7.0 PBS buffer (pre-cooled at 4℃) at a material-to-liquid ratio of 1:10, and extract at 4℃ with low-speed magnetic stirring for 3h. After extraction, centrifuge at 4℃ and 10000r / min for 10min, and take the supernatant. Aliquot the supernatant into 10kDa ultrafiltration centrifuge tubes, centrifuge at 4℃ and 8000r / min for ultrafiltration, concentrate to 1 / 3 of the original volume, add an equal volume of ultrapure water and wash repeatedly 3 times, collect the retentate, centrifuge at 4℃ and 10000r / min for 10min, filter the supernatant through a 0.22μm PVDF membrane, and freeze at -20℃.

[0042] Comparative Example 2 This comparative example uses the same raw materials and operating steps as the example, but omits step (4) PEG-ammonium sulfate aqueous two-phase extraction. The crude extract obtained after defatting is directly concentrated by 10kDa ultrafiltration. The remaining steps are consistent with those of the example.

[0043] The specific operation is as follows: Take 200g of bovine pituitary gland powder prepared according to step (1) of Example 1, and perform supercritical CO2 defatting treatment according to step (2) of Example 1, and collect the defatted solids. Take 50g of defatted solids, add 500mL of pH 7.0 PBS buffer (pre-cooled at 4℃) at a material-to-liquid ratio of 1:10, and extract at 4℃ with low-speed magnetic stirring for 3h. After extraction, centrifuge at 4℃ and 10000r / min for 10min, and collect the supernatant. Dispense the supernatant into 10kDa ultrafiltration centrifuge tubes, centrifuge at 4℃ and 8000r / min for ultrafiltration, concentrate to 1 / 3 of the original volume, add an equal volume of ultrapure water and repeatedly replace and wash 3 times, collect the retentate, centrifuge at 4℃ and 10000r / min for 10min, filter the supernatant through a 0.22μm PVDF membrane, and freeze at -20℃.

[0044] Comparative Example 3 This comparative example uses the same raw materials and operating steps as the example, but omits step (2) supercritical CO2 defatting. Instead, the bovine pituitary dry powder is directly extracted with PBS buffer and then subjected to aqueous two-phase extraction. The remaining steps are consistent with those in the example.

[0045] The specific operation is as follows: Take 50g of bovine pituitary powder prepared according to step (1) of Example 1, add 500mL of pH 7.0 PBS buffer (pre-cooled at 4℃) at a material-to-liquid ratio of 1:10, and extract at 4℃ with low-speed magnetic stirring for 3h. After extraction, centrifuge at 4℃ and 10000r / min for 10min, and take the supernatant to obtain the crude pituitary extract. Prepare a PEG-ammonium sulfate aqueous two-phase system (total mass 100g): add 13g of PEG4000, 16g of anhydrous ammonium sulfate, and 51g of ultrapure water in sequence, and stir at room temperature until completely dissolved. Take 20g of the crude pituitary extract and add it to the prepared aqueous two-phase system, vortex to mix thoroughly, let stand in a 25℃ water bath for 30min, centrifuge at 5000r / min for 10min at room temperature, the system forms two layers, and slowly aspirate the upper PEG phase. The PEG phase was aliquoted into 10kDa ultrafiltration centrifuge tubes and concentrated to 1 / 3 of its original volume by ultrafiltration at 4℃ and 8000r / min. An equal volume of ultrapure water was added and the tubes were washed three times by repeated replacement. The retentate was collected and centrifuged at 4℃ and 10000r / min for 10 min. The supernatant was filtered through a 0.22μm PVDF membrane and stored frozen at -20℃.

[0046] Comparative Example 4 This comparative example uses the same raw materials and operating steps as the example, but the supercritical CO2 degreasing temperature in step (2) is adjusted to 60°C (40°C in the example). The remaining conditions and subsequent steps are the same as those in the example.

[0047] Comparative Example 5 This comparative example uses the same raw materials and operating steps as the example, but replaces the aqueous two-phase system in step (4) with the PEG4000-potassium phosphate system (13% PEG4000 + 16% potassium phosphate), and the remaining steps are consistent with the example.

[0048] Comparative Example 6 This comparative example uses a traditional process to prepare bovine pituitary extract. The specific procedures are as follows: Fresh bovine pituitary glands were thawed at 2-8℃, and the capsule and connective tissue were removed. The glands were rinsed five times with pre-cooled PBS, and the surface moisture was blotted dry. The glands were then homogenized using a tissue homogenizer at 4℃ (10000 rpm, 30-second pause after every 30 seconds of homogenization, totaling 10 minutes of homogenization). The homogenate was transferred to a beaker, and the pH was adjusted to 3.0 with 1 mol / L HCl. The mixture was then stirred and extracted at 4℃ for 12 hours. After extraction, the mixture was centrifuged at 4℃ and 12000 rpm for 20 minutes, and the supernatant was collected. Pre-cooled anhydrous ethanol was added to the supernatant to a final concentration of 75%, and the mixture was allowed to stand at -20℃ overnight to precipitate. The next day, the precipitate was collected by centrifugation at 4℃ and 12000 rpm for 20 minutes. The precipitate was reconstituted with a small amount of PBS (pH 7.0), transferred to a dialysis bag (molecular weight cutoff 1 kDa), and dialyzed against PBS buffer at 4°C for 48 h, with the dialysate changed 6 times during this period. After dialyzing, the contents were centrifuged at 10,000 rpm for 10 min at 4°C, and the supernatant was filtered through a 0.22 μm PVDF membrane and stored frozen at -20°C.

[0049] Experimental Section Experiment 1: Determination of Total Protein Concentration The total protein concentration of the bovine pituitary extract prepared in Example 1 was determined using the BCA method. The following steps were followed: (1) According to the kit instructions, mix reagents A and B at a ratio of 50:1 (v / v) to prepare the colorimetric working solution; (2) Add 20 μL of BSA standard to wells 1-8 respectively, so that the final BSA concentration (μg / mL) is 0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 respectively; (3) Dilute the sample 10-fold with 1×PBS and add 20 μL to the wells of a 96-well plate. Repeat the process 3 times for each sample. (4) Add 200 μL of colorimetric working solution, mix well, incubate at 37°C for 30 min, and cool to room temperature; (5) The OD value of each sample and BSA standard at 562 nm was measured using an enzyme-linked immunosorbent assay (ELISA) reader. ⑹ Plot a standard curve and calculate the sample protein concentration from the curve equation.

[0050] The concentrations and corresponding OD values ​​of BSA standards are shown in Table 1.

[0051] Table 1. BSA protein standard curve data

[0052] A standard curve was plotted with the standard protein concentration on the x-axis and the absorbance value on the y-axis. Figure 1 The resulting standard curve equation is: Y = 0.9982X + 0.1316, R0 2 =0.9982. Under the same conditions, the OD value of the bovine pituitary extract was measured to be 0.345, and the protein concentration in the extract was calculated to be 2.14 mg / mL according to the above standard equation. This indicates that the process can effectively enrich proteins and meet the requirements for subsequent cell culture experiments.

[0053] Experiment 2: ELISA detection of active substance levels in extracts The levels of the main active substances (growth hormone GH, transforming growth factor β1 (TGF-β1), insulin-like growth factor-1 (IGF-1), and thyroid-stimulating hormone (TSH)) in the bovine pituitary extract prepared in Example 1 were detected by ELISA. The experimental method is as follows: (1) Equilibrate the kit to room temperature and dilute the concentrated washing buffer and standards according to the instructions; (2) Add 50 μL of standard and diluted specimen to a 96-well plate, and set up a blank control; (3) Seal the plate and incubate at 37℃ for 60 minutes. (4) Discard the liquid, add detergent and let stand for 30 seconds, shake dry, repeat 5 times, and then pat dry on absorbent paper; (5) Add 50 μL each of substrate A and substrate B; (6) Incubate at 37℃ in the dark for 15 minutes to develop color; (7) Add 50 μL of stop solution to terminate the reaction; (8) Read the OD value at 450nm using an ELISA reader within 15 minutes.

[0054] (9) Calculate the concentration of each growth factor.

[0055] The specific experimental data obtained are shown in Table 2: Table 2 Results of Detection of Active Substances in Extracts

[0056] Enzyme-linked immunosorbent assay (ELISA) results showed high concentrations of GH, TGF-β1, and IGF-1, while also retaining trace amounts of active substances. This indicates that the bovine pituitary extract obtained by this method effectively preserves endogenous pituitary active substances.

[0057] Experiment 3: Assay of rat BMSCs viability cultured with bovine pituitary extract Take well-grown rat BMSCs cells, digest them, and adjust the cell concentration to 1×10⁻⁶. 4 Cells were seeded at a density of 1 / mL in 6-well plates. The experimental group received complete culture medium containing 6% FBS (fetal bovine serum) + 3% BPE (bovine pituitary extract), while the control group received complete culture medium containing 10% FBS. After incubation at 37°C and 5% CO2 for 72 hours, trypsin was added to digest the cells and obtain a single-cell suspension. A suitable amount of trypan blue staining solution was added to the suspension. The total number of cells and the number of viable cells in each group were counted using an automated cell analyzer. Triple replicates were performed per well, and the mean ± standard deviation was calculated.

[0058] The specific experimental data are shown in Table 3.

[0059] Table 3. Cell viability test results ; The above data indicate that the cell survival rate in the medium containing 3% BPE was not significantly different from that in the control group. Furthermore, the cells exhibited a spindle-shaped morphology and no abnormal apoptosis. This suggests that the addition of low concentrations of bovine pituitary extract did not induce abnormal growth of rat BMSCs.

[0060] Experiment 4: CCK-8 assay to detect the proliferation rate of rat BMSCs under different conditions (1) Take well-grown BMSCs cells and use 5×10 3 Inoculate 96-well plates with 3 replicates per well; (2) Set up 10% FBS + basal culture medium as the control group and 6% FBS + 3% BPE + basal culture medium as the experimental group; (3) Incubate at 37℃ in a 5% CO2 incubator for 1-7 days; (4) Starting 24 hours after inoculation, cell absorbance was measured at fixed times every day. 10 μL of ccK-8 solution was added to each well and incubated for 2 hours. (5) Use an ELISA reader to read the OD value at 450 nm.

[0061] ⑹ Draw the growth curve.

[0062] The specific experimental data are shown in Table 4.

[0063] Table 4 OD at different incubation times 450 Test results

[0064] Table 4 shows that, compared with the control group, the experimental group showed faster cell growth. 3% BPE significantly promoted cell growth, enabling the cell count to reach a higher level in a short time. Adding a certain proportion of BPE during cell culture can support cell growth and proliferation, and shorten the culture time.

[0065] Results of rat BMSCs cell proliferation are shown in Figure 2 .Depend on Figure 2 As can be seen, the cell growth curves of both groups were S-shaped, with the cell latency period from 1 to 3 days, the logarithmic growth phase from 3 to 6 days, the peak proliferation on day 6, and the plateau phase on day 7. At the same culture time point, the OD450 values ​​of the 6% FBS + 3% BPE experimental group were higher than those of the 10% FBS control group.

[0066] Experiment 5: Detection of transcription factors related to cell stemness The effects of bone marrow irradiation (BPE) on rat BMSCs stem cells were evaluated by detecting the stem cell-related transcription factors OCT4, SOX2, and NANOG using RT-qPCR. The methods are as follows: (1) Rat BMSCs cells were cultured in a six-well plate with cell culture medium containing 6% FBS + 3% BPE and 10% FBS. Culture was stopped when the cells reached passage P7 and the growth density reached 80%-90%. (2) Discard the original culture medium and wash with PBS 2-3 times to remove residue; (3) Add 500 μL of Trizol lysis buffer to each well and pipette to lyse the cells; (4) Transfer the cell culture to an RNase-free EP tube and place on ice for 15 min; (5) Add 500 μL of Trizol, then add 200 μL of chloroform, mix gently, and let stand at room temperature for 3 minutes; (6) Centrifuge at 12,000 rpm for 15 min at low temperature to separate the organic layer from the aqueous phase; (7) Take water and add an equal amount of isopropanol, then place on ice for 10 minutes; (8) Centrifuge at 4℃ and 12000rpm for 10min, then discard the supernatant; (9) Wash the RNA precipitate with pre-cooled 75% RNase-free ethanol and centrifuge at high speed for 15 min under the same conditions; (10) Invert the RNA precipitate at room temperature to dry, dissolve the RNA in RNase-free water, and synthesize cDNA according to the instructions of the reverse transcription kit. Store at -20℃ for later use.

[0067] 11. Using cDNA as a template, prepare the reaction system according to the qPCR kit. The primer sequences are shown in Table 5 below.

[0068] Table 5 Primer sequences

[0069] Set the reaction conditions on the PCR instrument as follows: pre-denaturation 95℃, 1 min; denaturation 95℃, 20 s; annealing 60℃, 30 s; extension 72℃, 30 s, for 40 cycles. Each sample was tested in triplicate. The reaction Ct value was obtained, using GAPDH as an internal control, and 2... -ΔΔCt The relative gene expression levels were analyzed using [a specific method]. All experimental data were [data missing]. ±s represents.

[0070] For details, please see [link / details]. Figure 3 In the figure, ns: P > 0.05; *: P < 0.05.

[0071] according to Figure 3 It can be seen that there was no statistically significant difference in OCT4 mRNA levels between the experimental group and the control group (P>0.05), while SOX2 and NANOG showed higher expression levels in the experimental group compared to the control group (P<0.05). The study found that the SOX2 gene plays an important role in regulating stem cell proliferation and inhibiting premature differentiation, while the NANOG gene mainly functions to maintain cell pluripotency and delay cell aging. Experiments showed that BPE upregulated the expression levels of SOX2 and NANOG genes after culturing rat BMSCs, and no stem cell loss occurred. This indicates that the bovine pituitary extract prepared in this invention has a certain effect on keeping stem cells in an undifferentiated state, delaying aging, and inhibiting spontaneous differentiation.

[0072] Experiment 6: Batch Consistency and Quality Comparison of Bovine Pituitary Extracts Bovine pituitary extracts prepared in Examples 1, 2, 3, and Comparative Examples 1-6 were taken respectively, and the protein concentration was uniformly adjusted to 2.0 g / dL. The following indicators were then systematically measured and compared: Detection indicators and methods: (1) Total protein purity (SDS-PAGE gel optical density scanning method): Take an equal amount of protein (20 μg / well) for 12% SDS-PAGE electrophoresis. After Coomassie Brilliant Blue R-250 staining, use a gel imaging system (Bio-Rad ChemiDoc) to scan. Use Image Lab software to analyze the percentage of the target active peptide region (molecular weight 10-30 kDa) in the total protein gray integral as the purity index.

[0073] (2) Growth hormone (GH) retention rate: The GH concentration of each sample was determined by ELISA method in Experiment 2. The GH detection value of Example 1 (246.33 ng / mL) was used as the baseline (100%) to calculate the relative GH retention rate of each comparative example and Examples 2 and 3.

[0074] (3) Lipid residue: The total lipid content was determined by vanillin-phosphate method. Based on the total lipid content of bovine pituitary dry powder raw material (the actual value was 52.3 mg / g dry powder), the degreasing rate of each process and the lipid residue in the product (unit: mg / g protein) were calculated.

[0075] (4) Nucleic acid residue: The A260 absorbance value (1A260≈40μg / mLRNA) was determined by ultraviolet spectrophotometry, and the residual nucleic acid content in the extract was calculated (unit: μg / mg protein).

[0076] (5) Ultrafiltration membrane flux decay rate: Record the ultrafiltration membrane flux (LMH, L·m⁻¹) after processing 100 mL of feed solution during the ultrafiltration concentration process in step (5) of each process. -2 ·h -1 The percentage attenuation was used to evaluate the impact of different pretreatment methods on membrane fouling load.

[0077] The experimental results are shown in Table 6.

[0078] Table 6. Comparison of the quality of bovine pituitary extracts prepared by different processes

[0079] Note: Comparative Example 6 uses a traditional process that does not employ an ultrafiltration step, therefore no flux decline rate data is available.

[0080] As can be seen from Table 6, the bovine pituitary extracts prepared in Examples 1-3 of this invention are significantly superior to those in Comparative Examples 1-6 in all key quality indicators, specifically in the following aspects: I. Product Purity The purity of Examples 1-3 (66.9%-68.3%) was approximately 2.4 times that of Comparative Example 6 using the conventional process, and approximately 2.1 times that of Comparative Example 1. Even compared to Comparative Examples 2 (45.8%) and 3 (52.4%), which only lacked a single purification unit, the purity of the Examples was significantly improved. This indicates that supercritical defatting and aqueous two-phase extraction are not simply additive, but achieve a purification gain effect through a chain-like synergistic mechanism of lipid removal, phase interface stabilization, efficient phase separation, and reduced membrane fouling.

[0081] II. Retention of Active Substances Example 1 showed the highest GH retention rate, while Examples 3 and 2 also maintained above 90%, indicating that the supercritical temperature of 35-45℃, aqueous two-phase PEG4000 10%-16%, and ammonium sulfate 12%-18% of the present invention have excellent protective effects on heat-sensitive and chemically sensitive active peptides. In contrast, in Comparative Example 4, simply raising the defatting temperature to 60℃ caused the GH retention rate to plummet to 62.6%, proving that temperatures exceeding 45℃ will lead to irreversible activity loss. In Comparative Example 6, the traditional process, due to acidic and organic solvent treatment, resulted in a GH retention rate of less than 50%, further confirming the necessity of the mild conditions of the present invention.

[0082] III. Impurity Removal Effectiveness Lipid removal: The total residual lipid content (2.0-2.3 mg / g protein) in Examples 1-3 was at a very low level, similar to that of Comparative Examples 2 (3.2), 4 (2.8), and 5 (2.3) after defatting, but significantly better than that of Comparative Examples 1 (48.6) and 3 (41.5) without defatting, and Comparative Example 6 (52.7) using the conventional process. This demonstrates the high efficiency of the supercritical CO2 defatting step and shows that subsequent aqueous two-phase extraction and ultrafiltration do not introduce new lipid contamination.

[0083] Nucleic acid removal: The residual nucleic acid levels (4.2-4.5 μg / mg protein) in Examples 1-3 were significantly lower than those in Comparative Example 1 (24.3) and Comparative Example 2 (31.5) without aqueous two-phase extraction, indicating that the PEG-ammonium sulfate aqueous two-phase system can efficiently partition nucleic acids to the salt phase. Of particular note is that although Comparative Example 3 was not defatted, it underwent aqueous two-phase extraction, resulting in a residual nucleic acid level (6.2) close to that of the examples. However, due to its excessively high lipid residue (41.5), the purity was still relatively low (52.4%). Defatting addresses the lipid issue, while the aqueous two-phase system addresses the issues of nucleic acid and impurities. In Comparative Example 5, after replacing the aqueous two-phase system with a potassium phosphate system, the residual nucleic acid level (16.4) significantly increased, demonstrating that the preferred PEG-ammonium sulfate system of this invention has superior partition selectivity for nucleic acids.

[0084] IV. Feasibility of Ultrafiltration Technology The ultrafiltration membrane flux decay rates of Examples 1-3 were only 8.2%-9.3%, demonstrating that the membrane flux remained almost constant during ultrafiltration, supporting long-term, large-scale continuous concentration operations. In contrast, Comparative Example 1 exhibited a flux decay rate as high as 73.5%, with lipids, nucleic acids, and extraneous proteins in the feed solution rapidly forming a dense fouling layer on the membrane surface. This caused the ultrafiltration process to stall due to a sudden drop in flux within a short time, severely limiting the feasibility of industrial scale-up. The decay rates of Comparative Examples 2 and 3 were 35.8% and 58.4%, respectively, significantly higher than the examples, indicating that a single purification unit cannot provide sufficient fouling protection for the ultrafiltration membrane. The decay rates of Comparative Examples 4 and 5 were also higher than the examples, demonstrating that optimizing only a single step parameter cannot fully replace a complete synergistic purification system.

Claims

1. A method for preparing bovine pituitary extract, characterized in that, Includes the following steps: (1) Bovine pituitary gland was freeze-dried and pulverized at low temperature to obtain bovine pituitary gland powder; (2) Place the bovine pituitary powder obtained in step (1) into a supercritical reactor and perform supercritical CO2 degreasing treatment to collect the degreased solids; (3) Extract the defatted solid obtained in step (2) with buffer solution, centrifuge and collect the supernatant to obtain the pituitary crude extract; (4) The crude pituitary extract obtained in step (3) was added to the PEG-ammonium sulfate aqueous two-phase system for extraction, and the PEG phase was collected; (5) The PEG phase obtained in step (4) is concentrated by ultrafiltration, washed, and the retentate is collected, filtered and sterilized to obtain bovine pituitary extract. Among them, the supercritical defatting in step (2), the aqueous two-phase extraction in step (4), and the ultrafiltration in step (5) constitute a synergistic purification system: supercritical defatting removes lipid-soluble impurities, eliminates their interference with the stability of the phase interface of the aqueous two-phase system, and improves the phase separation efficiency and target protein recovery rate of the aqueous two-phase extraction; aqueous two-phase extraction removes high molecular weight impurities, polysaccharides and nucleic acids, reduces the pollution load of the ultrafiltration membrane, and protects the membrane flux.

2. The method according to claim 1, characterized in that, Steps (2), (4), and (5) remove impurities in order of increasing polarity and decreasing molecular weight: Step (2) removes non-polar and weakly polar lipids to eliminate interference from aqueous two-phase emulsification and ensure clear phase separation; Step (4) distributes polar macromolecular proteins and polysaccharides to the salt phase to reduce the fouling load on the ultrafiltration membrane; Step (5) retains the target peptide and removes residual small molecule salts and PEG.

3. The method according to claim 2, characterized in that, The supercritical CO2 degreasing process conditions described in step (2) are: temperature 40℃, pressure 35MPa, static soaking for 30min, dynamic circulation degreasing for 1.5h, and CO2 flow rate 20L / h.

4. The method according to claim 1, characterized in that, After degreasing is completed in step (2), the pressure is released to atmospheric pressure at a rate of 0.2-0.5 MPa / min.

5. The method according to claim 1, characterized in that, In step (4), the PEG-ammonium sulfate aqueous two-phase system has a mass fraction of 13% for PEG4000 and a mass fraction of 16% for anhydrous ammonium sulfate. The extraction conditions are: standing in a water bath at 20-30℃ for 20-30 min, and then centrifuging at 4000-6000 r / min at room temperature for 8-15 min.

6. The method according to claim 1, characterized in that, In step (5), the ultrafiltration is carried out using an ultrafiltration centrifuge tube with a molecular weight cutoff of 10 kDa. The tube is centrifuged at 4°C and 6000-10000 r / min to concentrate the volume to 1 / 4-1 / 2 of the original volume. An equal volume of ultrapure water is added and the tube is repeatedly washed and replaced 2-4 times.

7. The method according to claim 1, characterized in that, Step (1) specifically includes: thawing the bovine pituitary gland at low temperature, removing the capsule and connective tissue, rinsing with pre-cooled PBS, slicing into thin slices, pre-freezing at -80℃ and then transferring to a vacuum freeze dryer with a vacuum degree ≤10Pa, a partition temperature of -20℃ to 20℃, and a total freeze-drying time of 30-42h; after freeze-drying, the bovine pituitary gland is frozen and embrittled with liquid nitrogen, intermittently pulverized at low temperature, and passed through an 80-mesh sieve to obtain bovine pituitary gland dry powder.

8. The method according to claim 1, characterized in that, The buffer solution mentioned in step (3) is a PBS buffer with pH=6.8-7.4, and the material-to-liquid ratio is (1:8)-(1:15). It is stirred and extracted at 2-8℃ for 2-5 hours, and then centrifuged at 2-8℃ and 8000-12000r / min for 8-15 minutes.

9. Bovine pituitary extract prepared by the method according to any one of claims 1-8.

10. The application of the bovine pituitary extract according to claim 9 in the preparation of cell culture medium additives, characterized in that, The extract can promote the proliferation of mesenchymal stem cells and maintain their stemness; the bovine pituitary extract upregulates the gene expression levels of stem cell stemness-related transcription factors SOX2 and NANOG.